Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lein

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Der Urologe. Ausg. A|July 14, 2007
[New serum markers of bone metastasis in prostate carcinoma]M Lein, A Ramankulov, C Stephan, et al.
The Journal of Urology|April 29, 1998
Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostateK Jung, A Meyer, M Lein, et al.
Surgical Endoscopy|October 7, 2006
Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive proceduresS Beutner, M May, B Hoschke, et al.
The International Journal of Biological Markers|November 1, 2002
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adultsK Jung, M Lein, K v Hösslin, et al.
Clinical Biochemistry|August 1, 1997
Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in bloodM Lein, L Nowak, K Jung, et al.
Journal of Cancer Research and Clinical Oncology|March 14, 1998
Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balanceK Jung, B Friedrich, I Türk, et al.
The Prostate|February 18, 1998
Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspectsK Jung, M Lein, N Ulbrich, et al.
Urology|March 29, 2000
ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulationC Stephan, K Jung, B Brux, et al.
Anticancer Research|May 1, 2001
Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosisM Lein, K Jung, U Elgeti, et al.
Clinical Chemistry|March 3, 1999
A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasiaK Jung, B Brux, A Knäbich, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Der Urologe. Ausg. A|July 14, 2007
[New serum markers of bone metastasis in prostate carcinoma]M Lein, A Ramankulov, C Stephan, et al.
The Journal of Urology|April 29, 1998
Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostateK Jung, A Meyer, M Lein, et al.
Surgical Endoscopy|October 7, 2006
Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive proceduresS Beutner, M May, B Hoschke, et al.
The International Journal of Biological Markers|November 1, 2002
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adultsK Jung, M Lein, K v Hösslin, et al.
Clinical Biochemistry|August 1, 1997
Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in bloodM Lein, L Nowak, K Jung, et al.
Journal of Cancer Research and Clinical Oncology|March 14, 1998
Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balanceK Jung, B Friedrich, I Türk, et al.
The Prostate|February 18, 1998
Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspectsK Jung, M Lein, N Ulbrich, et al.
Urology|March 29, 2000
ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulationC Stephan, K Jung, B Brux, et al.
Anticancer Research|May 1, 2001
Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosisM Lein, K Jung, U Elgeti, et al.
Clinical Chemistry|March 3, 1999
A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasiaK Jung, B Brux, A Knäbich, et al.
Pageof 11